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Abstract
Background: Our study aimed to describe the concordance of chlamydia infections of the rectum and urethra in
men who have sex with men (MSM) and their male partners.
Methods: This was a cross-sectional study of chlamydia in MSM and their male sexual partners both attending
Melbourne Sexual Health Centre (MSHC), Australia, between February 2011 and March 2015. We excluded
partnerships where testing for chlamydia at both the rectum and urethra were not undertaken.
Results: Our study included 473 partnerships (946 men). 30 men had urethral chlamydia, of whom 14 (47%, 95% CI
28 to 66) had a partner with rectal chlamydia. 46 men had rectal chlamydia, of whom 14 (30%, 95% CI 18 to 46)
had a partner with urethral chlamydia. The proportion of men with rectal chlamydia when their partner had
urethral chlamydia was significantly higher than the proportion of men with urethral chlamydia when their partner
had rectal chlamydia (McNemar’s p = 0.02).
Conclusions: This is the first study of chlamydia concordance in male sexual partnerships and suggests that
transmission of chlamydia between the urethra and rectum may be less efficient than has been reported for
transmission between the urethra and cervix in heterosexual couples. It also suggests that transmission from the
urethra to the rectum may be more efficient than in the opposite direction.
Keywords: Chlamydia trachomatis [B03.440.190.190.190.750], Homosexuality [F01.145.802.975.500], Sexual Partners
[M01.778], Disease Transmission, Infectious [N06.850.310], Chlamydia, Men who have sex with men, Transmission,
Partnership, Couple, Dyad
Background
Chlamydia trachomatis remains one of the most common
bacterial sexually transmissible infections (STI) worldwide
[1, 2]. Chlamydia notifications have been increasing in
Australia since the 1990s, and have doubled over the decade
from 2004 to 2013, [3] due to both increased testing and a
true increase in the prevalence of infection both in hetero-
sexuals and men who have sex with men (MSM) [4–7].
New biomedical HIV prevention strategies such as pre-
exposure prophylaxis and treatment as prevention will
hopefully result in a significant reduction in new HIV trans-
missions, but there are concerns that the effective preven-
tion of HIV will result in behavioural changes that will
further increase the rates of bacterial STIs among MSM.
To address the rising rates of chlamydia, health depart-
ments have sought strategies to control this infection.
These strategies include screening programmes, and such
programmes have been evaluated in heterosexuals, but the
most recent and largest clinical trial did not show a sig-
nificant effect of screening on the prevalence of infection,
even when annual screening rates reached 30% [8].
Screening programmes and other public health inter-
ventions can be evaluated using mathematical models. But
to date no model of chlamydia transmission in MSM has
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been published, and there is a paucity of data on key
information needed to develop such models. In MSM this
information would include the natural duration of infec-
tion of the urethra and rectum, the transmission probabil-
ity between these sites, and the potential role of chlamydia
of the pharynx.
The aim of this study was to analyse the concordance
of chlamydia infections at the rectum and urethra in
male-male partnerships, and to use this data to infer the
likelihood of transmission of chlamydia between the ur-
ethra and rectum within partnerships. Such information
can be used to build mathematical models of chlamydia
transmission, and may be useful for clinicians when
counselling patients about their chlamydia infections.
Methods
This was a cross-sectional study of chlamydia diagnoses of
the urethra and rectum in MSM and their male sexual
partners when both attended Melbourne Sexual Health
Centre (MSHC) on the same day. MSHC is the major
public sexual health clinic in Melbourne, Australia. It pro-
vides a free walk-in service and no referrals are required.
Over the study period it provided approximately 35,000
consultations annually, and about 37% of consultations
were for MSM [9]. All patients complete a computer-
assisted self-interview (CASI) that collects their demo-
graphic details (e.g., age) and sexual behaviours (e.g., num-
ber of casual partners in the last three months, condom
use with regular and casual partners during insertive and/
or receptive anal sex in the last three months) [10]. From
March 2011 onwards, CASI included the additional ques-
tion “Is your partner also being seen today at this clinic?”.
Patients who answered “yes” to this question were asked
for their partner’s name. We initially included all MSM
who answered yes to this question and whose partner we
could identify, and who had testing for chlamydia between
March 2011 and February 2015. Partners were paired and
assigned a unique “partnership number”. MSHC uses an
electronic medical record system in which clinicians enter
a diagnosis code when a patient attends for a consultation.
We offered screening for chlamydia on rectal swabs and
first void urine samples in all MSM, in line with Australian
STI screening guidelines for MSM [11]. During the study
period, the screening protocol at MSHC did not include
testing for pharyngeal chlamydia. Chlamydia was tested
using a strand displacement assay (Becton Dickinson, New
Jersey, USA). Urethral and rectal chlamydia positivity was
calculated as the number of positive tests divided by the
number of tests performed.
All statistical analyses were performed using Stata (ver-
sion 13.1, StataCorp LP). The 95% confidence interval (CI)
for chlamydia positivity was calculated using the ‘exact’
binomial distribution [12]. The positivity of chlamydia
results obtained at the urethra and rectum for each person
in each partnership was paired and compared using the
McNemar’s test of significance. Our primary analysis
examined the concordance of chlamydia at the urethra and
rectum, and was based on 473 partnerships in which both
men were screened for urethral and rectal chlamydia on
the same day. A secondary analysis was limited restricted
to 406 partnerships where both men did not have symp-
toms of urethritis or proctitis, to remove possible selection
bias as a result of the presence of symptoms as the primary
reason of attending the clinic. Another secondary analysis
was restricted to 352 partnerships who reported anal sex
without condoms to exclude the protective effect of
condom use.
Results
During the study period, 1464 MSM attended MSHC with
their partner on the same day, consisting of 732 partner-
ships, their demographics are described in Table 1. In 473
partnerships (946 men, 65% of total), both men were
screened for urethral and rectal chlamydia on the same day.
In 57 partnerships (114 men) at least one man had symp-
tomatic urethritis, including 6 partnerships where both
men had symptomatic urethritis. In 22 partnerships (44
men) at least one man had symptomatic proctitis, including
two partnerships in which both men had symptomatic
proctitis. There were 406 partnerships (812 men) in which
both partners had complete testing for chlamydia and
neither partner had symptomatic proctitis or urethritis
(Additional file 1: Figure S1). Table 2 describes the fre-
quency and proportion of chlamydia infections amongst
these 946 men and 812 men respectively.
Of the 946 men, 30 had urethral chlamydia, of whom 14
(47%, 95% CI 28 to 66) had a partner with rectal chlamydia.
Of the 946 men, 46 men had rectal chlamydia, of whom 14
(30%, 95% CI 18 to 46) had a partner with urethral
Table 1 Demographic and behavioural characteristics of the
1464 men attended the Melbourne Sexual Health Centre with
their male partner on the same day
Median (IQR) Yes/total; % yes
Age (years) 28 (24 to 35)
Age difference (years) between
partners
4 (2 to 9)
HIV positive 54/1464 (4%)
CSP in last 3 months (yes vs no) 702/963 (73%)
Condoms for RAI with RSPa 530/1330 (40%)
Condoms for RAI with CSPa 1078/1311 (82%)
Condoms for IAI with RSPa 508/1321 (38%)
Condoms for IAI with CSPa 1060/1309 (81%)
Number of CSP in last 3 months
for those with CSP.
3 (1 to 5)
IQR interquartile range, RAI receptive anal intercourse, IAI insertive anal
intercourse, RSP regular sexual partner, CSP casual sexual partner
aConsistent condoms use at all times or no anal sex
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chlamydia (Table 3). The proportion of men with rectal
chlamydia when their partner had urethral chlamydia was
significantly higher than the proportion of men with ureth-
ral chlamydia when their partner had rectal chlamydia
(McNemar test; p = 0.02).
In a secondary analysis we excluded partnerships where
either partner had symptomatic urethritis or proctitis. Of
the 812 men in asymptomatic partnerships, 18 men had
urethral chlamydia, of whom 8 (44%, 95% CI 22 to 69)
had a partner with rectal chlamydia; and 35 men had rec-
tal chlamydia, of whom 8 (23%, 95% CI 10 to 40) had a
partner with urethral chlamydia (Table 4). The proportion
of men with rectal chlamydia when their partner had ur-
ethral chlamydia was significantly higher than the propor-
tion of men with urethral chlamydia when their partner
had rectal chlamydia (McNemar test; p = 0.005). Table 5
includes data on 704 men who reported anal sex without
condoms and proportions of chlamydia positivity are
similar to those in Tables 3 and 4.
Discussion
Our data provide the first estimate of the concordance
of chlamydia infection between the rectum and the
urethra in same-sex male partnerships. The data suggest
that the likelihood of chlamydia transmission between
men is lower than that reported between men and
women. In a study of 494 heterosexual partnerships that
included symptomatic individuals, chlamydia was found
in 68% of men with an infected female partner, and in
70% of women with an infected male partner [13]. These
male–female concordance rates are analogous to our
30.4% urethral chlamydia positivity in MSM with a part-
ner with rectal chlamydia, and our 46.7% rectal chla-
mydia positivity in MSM with a partner with urethral
chlamydia, respectively. The chlamydia concordance in
these heterosexual couples is significantly higher than
chlamydia concordance between MSM partners in our
study, suggesting that the transmission probability be-
tween MSM is lower than between heterosexual men and
women. This may explain why chlamydia is not much
more common in MSM than in heterosexuals whilst other
STIs such as gonorrhoea and syphilis are many times
more common in MSM [14]. However, the comparison
Table 2 Chlamydia positivity in MSM, by anatomic site
(individual MSM data, not grouped into partnerships), including
only MSM from partnerships in which both men were tested for






Chlamydia at any site 70/946; 7.4 (5.8 to 9.3) 48/812; 5.9 (4.4 to 7.8)
Urethral chlamydia 30/946; 3.2 (2.1 to 4.5) 18/812; 2.2 (1.3 to 3.5)
Rectal chlamydia 46/946; 4.9 (3.6 to 6.4) 35/812; 4.3 (3.0 to 5.9)
Both urethral and
rectal chlamydia
6/946; 0.6 (0.2 to 1.4) 5/812; 0.6 (0.2 to 1.4)
N =men tested; n = positive tests; MSM =men who have sex with men
Table 3 Concordance of rectal chlamydia and urethral chlamydia
between men in all 473 partnerships in which both men were









Rectum negative 884 16 900 1.8
(1.0 to 2.9)
Rectum positive 32 14 46 30.4
(17.7 to 45.8)











(McNemar’s test p = 0.02)
Each man is represented twice: once as a urethra and once as a rectum
Table 4 Concordance of rectal chlamydia and urethral
chlamydia between men in 406 partnerships in which both












Rectum negative 767 10 777 1.3
(0.6 to 2.4)















(McNemar’s test p = 0.005)
Each man is represented twice: once as a urethra and once as a rectum
Table 5 Concordance of rectal chlamydia and urethral










Rectum negative 652 12 664 1.8
(0.9 to 3.1)
Rectum positive 27 13 40 32.5
(18.6 to 49.1)










(McNemar’s test p = 0.02)
Each man is represented twice: once as a urethra and once as a rectum
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between heterosexuals and MSM is complicated by the
fact that MSM are likely to have more sexual partners and
concurrent sexual partners, as highlighted by the differ-
ence in sexual partner numbers in our study compared to
that found in heterosexual couples [13].
There was only one partnership in which both men had
urethral chlamydia in the absence of either man having
rectal chlamydia (Additional file 1: Table S1a), which sug-
gests that urethra-to-urethra transmission is uncommon.
Similarly, there were only two partnerships in which both
men had rectal chlamydia in the absence of either man
having urethral chlamydia (Additional file 1: Table S1b),
which suggests that rectum-to-rectum transmission is also
uncommon. These findings also support the notion that
pharyngeal-to-urethra and pharynx-to-rectum for chla-
mydia transmission is likely to be uncommon [15, 16].
We conducted secondary analyses to assess the effect of
any possible bias that may have resulted from symptom-
atic presentations or condom use. As expected, when
symptomatic presentations were excluded, the transmis-
sion probabilities were somewhat lower because including
symptomatic presentations may have biased towards
transmission having had occurred. When we included
only men who practised condomless anal sex, the trans-
mission probabilities were somewhat higher (33-52%) but
still lower than had been reported for heterosexuals.
Our data showed that 47% of partners of men with ur-
ethral chlamydia had rectal chlamydia while only 30% of
partners of men with rectal chlamydia had urethral chla-
mydia. This difference remained significant when the
analysis was restricted by symptoms and condom use.
While this cross-sectional study cannot determine the
direction of chlamydia transmission within each partner-
ship, the results suggest that transmission from the ur-
ethra to the rectum may be more likely than transmission
from the rectum to the urethra. These data do not reflect
a difference in transmission efficiency during a single ex-
posure, but instead describe the cumulative result of all
exposures. We did not further investigate the causes for
this difference, but it may be that the mechanics of anal
sex more efficiently facilitates urethra-to-rectum transmis-
sion than rectum-to-urethra transmission. The difference
in concordance should not be due to a difference in bac-
terial loads, as chlamydia loads have been shown to be
higher in the rectum than in the urethra [17]. Interest-
ingly, the aforementioned analysis in heterosexual partner-
ships found equal bidirectional transmission of chlamydia
between men and women, where 68% of the male partners
of infected women had chlamydia, and 70% of female
partners of infected men had chlamydia [13].
A limitation of our analysis is that chlamydia in the
pharynx was not screened for in our study. It is plausible
that men can acquire urethral or rectal chlamydia
through penile-oral sex, oral-anal contact, or the use of
saliva as a lubricant for penile-anal sex [18]; however,
direct evidence for these specific modes of transmission
is limited, and there is disagreement in the published lit-
erature on the role of pharyngeal chlamydia in overall
transmission. Studies have generally shown that rates of
pharyngeal chlamydia in MSM are low. A study of at-
tendees at sexual health clinic in Amsterdam found that
1.1% of MSM (95% CI 0.9 to 1.3) tested positive for
pharyngeal chlamydia, [15] which is low compared with
a positive rate of 9.8% for rectal chlamydia and 4.4% for
urethral chlamydia [15]. They also assessed rates of
spontaneous clearance, and found that at a median
follow-up time of 12 days (range 7–58) pharyngeal chla-
mydia had spontaneously cleared in 37.2% of MSM [15].
A 2014 study from Melbourne showed that urethral
chlamydia infection in MSM was strongly associated
with insertive penile-anal sex without condoms, whereas
urethral gonorrhoea and primary syphilis was not, lead-
ing the authors to hypothesise that pharyngeal infections
were significant contributors to transmission for urethral
gonorrhoea and primary syphilis, but not for urethral
chlamydia [19]. This observation is further supported by
a study from Seattle that showed that only 3% of ureth-
ral chlamydia cases were attributable to oral sex, com-
pared with 34% of urethral gonorrhoea cases [20]. In
contrast, findings from a study of MSM attending a sex-
ual health clinic in San Francisco in 2007 support the
role of oral sex as a risk factor for urethral chlamydia.
They found that men who reported penile-oral sex only,
not penile-anal sex, in the three months before testing
had a urethral chlamydia positive rate of 4.8% (95% CI
2.9-7.4), which was not significantly different from the
rate of urethral chlamydia of 7.0% (95% CI 5.6 to 8.6)
amongst men who reported insertive penile-anal sex
without condoms in the three months before testing
[21]. Similarly, the Sydney-based “Health In Men” (HIM)
study found that occasional (but not frequent) insertive
oral sex was a risk factor for urethral chlamydia in MSM
[18]. Whilst we were not able to assess the role of
pharyngeal chlamydia infection directly, our study found
relatively few men who had chlamydia of both the ur-
ethra and rectum (<10%). One explanation for this ob-
servation is that the pharynx is perhaps not commonly
involved in chlamydia transmission in MSM, as
pharyngeal chlamydia could potentially transmit to both
a partner’s urethra and rectum.
Our study has a number of other limitations. Firstly,
we had no data on chlamydia infections in sexual part-
ners other than the partner present on the day. Obvi-
ously, in every partnership at least one of the partners
must have had sexual contact with a third party who
had a chlamydia infection, but we are not able to deter-
mine in how many partnerships both partners separately
acquired chlamydia from a third party, as this would
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require testing all third parties for chlamydia and con-
ducting a molecular analysis of chlamydia serovars. A
recently-published study of chlamydia concordance in
heterosexual partnerships found that in 96.2% (51/53) of
chlamydia-concordant partnerships both partners had
the same chlamydia genotype (Schillinger et al., [22]).
This finding suggests that concordance represents trans-
mission within partnerships, but as described above, we
may not be able to extrapolate from heterosexual partner-
ships to same sex male partnerships. By not accounting
for instances where both partners acquired chlamydia
from a third party, we may have over-estimated the likeli-
hood of transmission between partners. Secondly, we did
not collect data on the duration of the relationship, the
frequency of sexual contact with that partner, whether
their last sex act was with that partner, or whether they
participated in group sex with that partner; hence it is not
possible for us to estimate the per act transmission prob-
ability. Hence, in both our study and in the study by
Quinn et al. of heterosexual partnerships, [13] chlamydia
concordance reflects cumulative transmission rather than
per-act transmission. Thirdly, we did not adjust for con-
dom use because the number of men reporting consistent
use of condoms for anal sex with their regular partner was
quite small (171 of 946 men, 18%, for insertive anal sex;
172 of 946 men, 18%, for receptive anal sex). However, we
did include a separate analysis of partnerships that re-
ported anal sex without condoms with their regular part-
ner, and found that the transmission estimates were
similar (Table 5). Fourthly, our analysis included only men
attending a single sexual health service with their male
partner on the same day. It is likely that some men in
partnerships did not present to our service on the same
day as their partner and hence were not included in our
study. We are not able to identify these partnerships, and
their exclusion may have introduced a selection bias.
Conclusions
These data provide an estimate of the relative probability of
transmission of chlamydia between the urethra and rectum,
which will assist in the development of mathematical models.
These models may then be used to assess novel public health
interventions to combat the rising rates of chlamydia infec-
tions amongst MSM. However, further work is needed to
clarify the role of pharyngeal chlamydia infections in overall
transmission rates. These data also suggest that transmission
of chlamydia between the urethra and rectum is less com-
mon than has been reported for transmission between the
urethra and cervix in heterosexual couples [13], which may
explain why the rate of chlamydia is not significantly higher
among MSM than among heterosexuals, unlike the rates of
other bacterial STIs. However, this inference needs to be
interpreted with caution, due to significant behavioural dif-
ferences between MSM couples and heterosexual couples.
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Additional file 1: Figure S1. Selection of cases. Table S1a. Urethral
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Rectal chlamydia in couples, after excluding couples with urethral
chlamydia. Every MSM included as a “partner 1” and as a “partner 2”.
Table S2. Chlamydia positivity by site. Men who tested for rectal
chlamydia, and their corresponding partner’s urethral chlamydia result.
Symptomatic urethritis cases excluded. “Partner 2” includes only men did
not have insertive penile-anal sex without condoms with casual and
regular partners in the three months before testing. (DOCX 30 kb)
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